nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.417	0.691	CbGbCtD
Propofol—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.186	0.309	CbGbCtD
Propofol—Respiratory acidosis—Riluzole—amyotrophic lateral sclerosis	0.0319	0.132	CcSEcCtD
Propofol—UGT1A8—tongue—amyotrophic lateral sclerosis	0.00892	0.112	CbGeAlD
Propofol—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00808	0.0334	CcSEcCtD
Propofol—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.00792	0.0328	CcSEcCtD
Propofol—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00605	0.025	CcSEcCtD
Propofol—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00596	0.0247	CcSEcCtD
Propofol—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00572	0.0237	CcSEcCtD
Propofol—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0225	CcSEcCtD
Propofol—FAAH—hindbrain—amyotrophic lateral sclerosis	0.00497	0.0625	CbGeAlD
Propofol—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0196	CcSEcCtD
Propofol—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00459	0.019	CcSEcCtD
Propofol—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0181	CcSEcCtD
Propofol—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0176	CcSEcCtD
Propofol—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0176	CcSEcCtD
Propofol—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.004	0.0165	CcSEcCtD
Propofol—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.004	0.0165	CcSEcCtD
Propofol—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0163	CcSEcCtD
Propofol—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0161	CcSEcCtD
Propofol—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00374	0.0155	CcSEcCtD
Propofol—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0147	CcSEcCtD
Propofol—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0145	CcSEcCtD
Propofol—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0139	CcSEcCtD
Propofol—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0138	CcSEcCtD
Propofol—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0136	CcSEcCtD
Propofol—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0132	CcSEcCtD
Propofol—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00306	0.0127	CcSEcCtD
Propofol—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0125	CcSEcCtD
Propofol—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0125	CcSEcCtD
Propofol—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0123	CcSEcCtD
Propofol—SCN2A—hindbrain—amyotrophic lateral sclerosis	0.00286	0.036	CbGeAlD
Propofol—FAAH—brainstem—amyotrophic lateral sclerosis	0.00285	0.0358	CbGeAlD
Propofol—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0111	CcSEcCtD
Propofol—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0109	CcSEcCtD
Propofol—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0108	CcSEcCtD
Propofol—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0108	CcSEcCtD
Propofol—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0107	CcSEcCtD
Propofol—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0106	CcSEcCtD
Propofol—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0105	CcSEcCtD
Propofol—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00243	0.0305	CbGeAlD
Propofol—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00954	CcSEcCtD
Propofol—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00934	CcSEcCtD
Propofol—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00926	CcSEcCtD
Propofol—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00222	0.0279	CbGeAlD
Propofol—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00904	CcSEcCtD
Propofol—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0089	CcSEcCtD
Propofol—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00214	0.027	CbGeAlD
Propofol—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00859	CcSEcCtD
Propofol—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00859	CcSEcCtD
Propofol—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00856	CcSEcCtD
Propofol—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00841	CcSEcCtD
Propofol—FAAH—medulla oblongata—amyotrophic lateral sclerosis	0.00199	0.025	CbGeAlD
Propofol—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00766	CcSEcCtD
Propofol—FAAH—spinal cord—amyotrophic lateral sclerosis	0.00177	0.0223	CbGeAlD
Propofol—Depression—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00695	CcSEcCtD
Propofol—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00687	CcSEcCtD
Propofol—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00683	CcSEcCtD
Propofol—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00683	CcSEcCtD
Propofol—SCN2A—brainstem—amyotrophic lateral sclerosis	0.00164	0.0206	CbGeAlD
Propofol—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00637	CcSEcCtD
Propofol—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00628	CcSEcCtD
Propofol—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00625	CcSEcCtD
Propofol—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00622	CcSEcCtD
Propofol—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00621	CcSEcCtD
Propofol—FAAH—nervous system—amyotrophic lateral sclerosis	0.00149	0.0188	CbGeAlD
Propofol—FAAH—central nervous system—amyotrophic lateral sclerosis	0.00144	0.0181	CbGeAlD
Propofol—FAAH—cerebellum—amyotrophic lateral sclerosis	0.0014	0.0177	CbGeAlD
Propofol—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00139	0.0175	CbGeAlD
Propofol—Chills—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00561	CcSEcCtD
Propofol—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00559	CcSEcCtD
Propofol—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00533	CcSEcCtD
Propofol—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00127	0.016	CbGeAlD
Propofol—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00523	CcSEcCtD
Propofol—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0051	CcSEcCtD
Propofol—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00123	0.0155	CbGeAlD
Propofol—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00121	0.005	CcSEcCtD
Propofol—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00497	CcSEcCtD
Propofol—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00488	CcSEcCtD
Propofol—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00478	CcSEcCtD
Propofol—Cough—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00475	CcSEcCtD
Propofol—SCN2A—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.0144	CbGeAlD
Propofol—FAAH—brain—amyotrophic lateral sclerosis	0.00114	0.0144	CbGeAlD
Propofol—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00472	CcSEcCtD
Propofol—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0047	CcSEcCtD
Propofol—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00463	CcSEcCtD
Propofol—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00463	CcSEcCtD
Propofol—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00462	CcSEcCtD
Propofol—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00453	CcSEcCtD
Propofol—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00448	CcSEcCtD
Propofol—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00444	CcSEcCtD
Propofol—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00444	CcSEcCtD
Propofol—Shock—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00437	CcSEcCtD
Propofol—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00434	CcSEcCtD
Propofol—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00429	CcSEcCtD
Propofol—SCN2A—spinal cord—amyotrophic lateral sclerosis	0.00102	0.0128	CbGeAlD
Propofol—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.001	0.00415	CcSEcCtD
Propofol—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000978	0.00405	CcSEcCtD
Propofol—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00402	CcSEcCtD
Propofol—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00097	0.0122	CbGeAlD
Propofol—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00097	0.0122	CbGeAlD
Propofol—SCN4A—nervous system—amyotrophic lateral sclerosis	0.000969	0.0122	CbGeAlD
Propofol—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00399	CcSEcCtD
Propofol—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00396	CcSEcCtD
Propofol—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00395	CcSEcCtD
Propofol—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000938	0.0118	CbGeAlD
Propofol—SCN4A—central nervous system—amyotrophic lateral sclerosis	0.000933	0.0117	CbGeAlD
Propofol—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00383	CcSEcCtD
Propofol—Pain—Riluzole—amyotrophic lateral sclerosis	0.000918	0.0038	CcSEcCtD
Propofol—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000885	0.00366	CcSEcCtD
Propofol—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.000865	0.0109	CbGeAlD
Propofol—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.000865	0.0109	CbGeAlD
Propofol—SCN2A—nervous system—amyotrophic lateral sclerosis	0.000858	0.0108	CbGeAlD
Propofol—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.000856	0.0108	CbGeAlD
Propofol—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00353	CcSEcCtD
Propofol—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00351	CcSEcCtD
Propofol—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00351	CcSEcCtD
Propofol—SCN2A—central nervous system—amyotrophic lateral sclerosis	0.000826	0.0104	CbGeAlD
Propofol—SCN2A—cerebellum—amyotrophic lateral sclerosis	0.000807	0.0102	CbGeAlD
Propofol—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00319	CcSEcCtD
Propofol—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.000763	0.00961	CbGeAlD
Propofol—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00314	CcSEcCtD
Propofol—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.000745	0.00937	CbGeAlD
Propofol—SCN4A—brain—amyotrophic lateral sclerosis	0.000741	0.00932	CbGeAlD
Propofol—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000735	0.00304	CcSEcCtD
Propofol—GABRB2—nervous system—amyotrophic lateral sclerosis	0.000728	0.00917	CbGeAlD
Propofol—GABRG2—nervous system—amyotrophic lateral sclerosis	0.000728	0.00917	CbGeAlD
Propofol—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00294	CcSEcCtD
Propofol—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000709	0.00892	CbGeAlD
Propofol—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.000701	0.00883	CbGeAlD
Propofol—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.000701	0.00883	CbGeAlD
Propofol—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.000686	0.00863	CbGeAlD
Propofol—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.000686	0.00863	CbGeAlD
Propofol—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00282	CcSEcCtD
Propofol—Rash—Riluzole—amyotrophic lateral sclerosis	0.000677	0.0028	CcSEcCtD
Propofol—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000676	0.0028	CcSEcCtD
Propofol—Headache—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00278	CcSEcCtD
Propofol—GABRA2—nervous system—amyotrophic lateral sclerosis	0.000666	0.00838	CbGeAlD
Propofol—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.000664	0.00836	CbGeAlD
Propofol—SCN2A—brain—amyotrophic lateral sclerosis	0.000656	0.00825	CbGeAlD
Propofol—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000643	0.0081	CbGeAlD
Propofol—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000641	0.00807	CbGeAlD
Propofol—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000638	0.00264	CcSEcCtD
Propofol—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000626	0.00788	CbGeAlD
Propofol—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000619	0.0078	CbGeAlD
Propofol—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000605	0.00762	CbGeAlD
Propofol—CYP2A6—brain—amyotrophic lateral sclerosis	0.000576	0.00725	CbGeAlD
Propofol—GABRB3—nervous system—amyotrophic lateral sclerosis	0.000559	0.00704	CbGeAlD
Propofol—GABRG2—brain—amyotrophic lateral sclerosis	0.000557	0.00701	CbGeAlD
Propofol—GABRB2—brain—amyotrophic lateral sclerosis	0.000557	0.00701	CbGeAlD
Propofol—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000552	0.00695	CbGeAlD
Propofol—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.000539	0.00678	CbGeAlD
Propofol—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000538	0.00677	CbGeAlD
Propofol—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000532	0.00669	CbGeAlD
Propofol—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.000526	0.00663	CbGeAlD
Propofol—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.00052	0.00654	CbGeAlD
Propofol—GABRA2—brain—amyotrophic lateral sclerosis	0.000509	0.0064	CbGeAlD
Propofol—GABRA1—brain—amyotrophic lateral sclerosis	0.000492	0.00619	CbGeAlD
Propofol—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000474	0.00596	CbGeAlD
Propofol—ALB—brain—amyotrophic lateral sclerosis	0.00046	0.00579	CbGeAlD
Propofol—GABRB3—brain—amyotrophic lateral sclerosis	0.000428	0.00538	CbGeAlD
Propofol—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000422	0.00532	CbGeAlD
Propofol—CYP1B1—brain—amyotrophic lateral sclerosis	0.000422	0.00531	CbGeAlD
Propofol—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.00039	0.00491	CbGeAlD
Propofol—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000379	0.00477	CbGeAlD
Propofol—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000376	0.00473	CbGeAlD
Propofol—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000365	0.0046	CbGeAlD
Propofol—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000356	0.00448	CbGeAlD
Propofol—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000343	0.00431	CbGeAlD
Propofol—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000335	0.00422	CbGeAlD
Propofol—CYP2C8—brain—amyotrophic lateral sclerosis	0.000323	0.00407	CbGeAlD
Propofol—CYP1A1—brain—amyotrophic lateral sclerosis	0.000298	0.00376	CbGeAlD
Propofol—CYP2B6—brain—amyotrophic lateral sclerosis	0.00029	0.00365	CbGeAlD
Propofol—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000286	0.00361	CbGeAlD
Propofol—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000282	0.00355	CbGeAlD
Propofol—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000276	0.00347	CbGeAlD
Propofol—CYP2E1—brain—amyotrophic lateral sclerosis	0.000272	0.00342	CbGeAlD
Propofol—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000271	0.00342	CbGeAlD
Propofol—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000265	0.00334	CbGeAlD
Propofol—CYP2D6—brain—amyotrophic lateral sclerosis	0.000215	0.00271	CbGeAlD
Propofol—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	5.79e-05	0.000767	CbGpPWpGaD
Propofol—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.71e-05	0.000757	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.64e-05	0.000748	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.64e-05	0.000747	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.64e-05	0.000747	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.63e-05	0.000745	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.56e-05	0.000737	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.53e-05	0.000733	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	5.49e-05	0.000727	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.44e-05	0.000721	CbGpPWpGaD
Propofol—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	5.41e-05	0.000717	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.34e-05	0.000707	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.34e-05	0.000707	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.33e-05	0.000706	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.29e-05	0.000701	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.27e-05	0.000698	CbGpPWpGaD
Propofol—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	5.24e-05	0.000695	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.23e-05	0.000693	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.23e-05	0.000693	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	5.19e-05	0.000688	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.19e-05	0.000688	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.96e-05	0.000658	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.93e-05	0.000653	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.93e-05	0.000653	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	4.92e-05	0.000651	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.88e-05	0.000647	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.84e-05	0.000642	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.81e-05	0.000637	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.8e-05	0.000636	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	4.79e-05	0.000634	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.78e-05	0.000634	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.78e-05	0.000633	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.74e-05	0.000627	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.7e-05	0.000623	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.7e-05	0.000623	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.69e-05	0.000621	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.6e-05	0.000609	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.54e-05	0.000601	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.53e-05	0.0006	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.52e-05	0.000599	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	4.52e-05	0.000599	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	4.52e-05	0.000599	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.51e-05	0.000597	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	4.51e-05	0.000597	CbGpPWpGaD
Propofol—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	4.5e-05	0.000595	CbGpPWpGaD
Propofol—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	4.5e-05	0.000595	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.48e-05	0.000594	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.48e-05	0.000594	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—APOE—amyotrophic lateral sclerosis	4.48e-05	0.000593	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.45e-05	0.000589	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	4.42e-05	0.000585	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	4.41e-05	0.000584	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.39e-05	0.000581	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	4.34e-05	0.000575	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	4.34e-05	0.000575	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.32e-05	0.000572	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.27e-05	0.000565	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.22e-05	0.000558	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	4.21e-05	0.000557	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.19e-05	0.000555	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.19e-05	0.000555	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.18e-05	0.000554	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	4.13e-05	0.000548	CbGpPWpGaD
Propofol—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	4.11e-05	0.000545	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.1e-05	0.000543	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	4.05e-05	0.000536	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.05e-05	0.000536	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	4.04e-05	0.000535	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	4.04e-05	0.000535	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.03e-05	0.000533	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.03e-05	0.000533	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.99e-05	0.000528	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.99e-05	0.000528	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.97e-05	0.000526	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.95e-05	0.000524	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.94e-05	0.000522	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	3.89e-05	0.000516	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.87e-05	0.000512	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.86e-05	0.000511	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.84e-05	0.000509	CbGpPWpGaD
Propofol—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.82e-05	0.000506	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	3.78e-05	0.000501	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.76e-05	0.000498	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.71e-05	0.000492	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.71e-05	0.000492	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.69e-05	0.000489	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.69e-05	0.000488	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.68e-05	0.000487	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.68e-05	0.000487	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.63e-05	0.00048	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	3.61e-05	0.000479	CbGpPWpGaD
Propofol—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	3.59e-05	0.000476	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.57e-05	0.000472	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.57e-05	0.000472	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.57e-05	0.000472	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.55e-05	0.000471	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.43e-05	0.000454	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.43e-05	0.000454	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.39e-05	0.00045	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.37e-05	0.000446	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	3.35e-05	0.000443	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.33e-05	0.00044	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	3.27e-05	0.000433	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—APOE—amyotrophic lateral sclerosis	3.27e-05	0.000433	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.25e-05	0.000431	CbGpPWpGaD
Propofol—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	3.25e-05	0.00043	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.23e-05	0.000427	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.17e-05	0.000419	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.16e-05	0.000418	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.14e-05	0.000416	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.14e-05	0.000416	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.13e-05	0.000414	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.12e-05	0.000414	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.07e-05	0.000406	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.03e-05	0.000402	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3e-05	0.000397	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.97e-05	0.000393	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.94e-05	0.00039	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.93e-05	0.000388	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.93e-05	0.000388	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.92e-05	0.000386	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.88e-05	0.000381	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.87e-05	0.00038	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.75e-05	0.000364	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.7e-05	0.000358	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.7e-05	0.000358	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.68e-05	0.000355	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.67e-05	0.000354	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.66e-05	0.000352	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	2.64e-05	0.00035	CbGpPWpGaD
Propofol—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	2.54e-05	0.000336	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.51e-05	0.000333	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.49e-05	0.00033	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.48e-05	0.000328	CbGpPWpGaD
Propofol—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	2.46e-05	0.000326	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.000321	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.000321	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.42e-05	0.000321	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.29e-05	0.000303	CbGpPWpGaD
Propofol—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000301	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.27e-05	0.000301	CbGpPWpGaD
Propofol—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	2.27e-05	0.000301	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000301	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.24e-05	0.000297	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.23e-05	0.000295	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.23e-05	0.000295	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.22e-05	0.000294	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000294	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000293	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.17e-05	0.000288	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.08e-05	0.000276	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.08e-05	0.000275	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000274	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.06e-05	0.000273	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.05e-05	0.000271	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.00027	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.03e-05	0.000269	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000267	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.96e-05	0.000259	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.94e-05	0.000257	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.000254	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.000254	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.88e-05	0.000249	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.88e-05	0.000249	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.87e-05	0.000247	CbGpPWpGaD
Propofol—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.87e-05	0.000247	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.86e-05	0.000246	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000246	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	1.83e-05	0.000243	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.000237	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	0.000233	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	0.000233	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.75e-05	0.000232	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.72e-05	0.000228	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.71e-05	0.000227	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.7e-05	0.000226	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000224	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.68e-05	0.000222	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000218	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.59e-05	0.000211	CbGpPWpGaD
Propofol—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.55e-05	0.000205	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.54e-05	0.000204	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.53e-05	0.000203	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000202	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.48e-05	0.000196	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000192	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000192	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000192	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.39e-05	0.000185	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.00018	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000179	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.000176	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.31e-05	0.000173	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.28e-05	0.00017	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	0.000166	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.000163	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.000158	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000158	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.17e-05	0.000155	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	0.000155	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.17e-05	0.000155	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000148	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.000146	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000145	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.000142	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.000139	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.01e-05	0.000134	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000133	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1e-05	0.000133	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.93e-06	0.000131	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.93e-06	0.000131	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.55e-06	0.000127	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.27e-06	0.000123	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.26e-06	0.000123	CbGpPWpGaD
Propofol—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.22e-06	0.000122	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	9.01e-06	0.000119	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.01e-06	0.000119	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	8.83e-06	0.000117	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.32e-06	0.00011	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.28e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.28e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.21e-06	0.000109	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.16e-06	0.000108	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.65e-06	0.000101	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	7.63e-06	0.000101	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	7.63e-06	0.000101	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.61e-06	0.000101	CbGpPWpGaD
Propofol—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	7.59e-06	0.0001	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.55e-06	0.0001	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.02e-06	9.29e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	6.81e-06	9.02e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.45e-06	8.54e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	6.26e-06	8.3e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	6.21e-06	8.22e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.17e-06	8.18e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.05e-06	8.01e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.7e-06	7.55e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.42e-06	7.17e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.31e-06	7.03e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.23e-06	6.92e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.2e-06	6.88e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.98e-06	6.59e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-06	6.18e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.29e-06	5.68e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.25e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	4.09e-06	5.42e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.64e-06	4.82e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	3.72e-05	CbGpPWpGaD
